C. R. Bard (BCR) Closes SenoRx (SENO) Acquisition
Up)
C. R. Bard, Inc. (NYSE: BCR) today announced that it has closed the previously disclosed acquisition of the outstanding shares of SenoRx, Inc. (Nasdaq: SENO). With the transaction completed, the SenoRx organization is now part of Bard’s Peripheral Vascular division.
You May Also Be Interested In
- UPDATE: SAP's (SAP) America Unit to Buy Ariba (ARBA) for $45/Share
- Dell (DELL) Could Be Considering Bid for Quest Software (QSFT)
- KKR (KKR) Said to Be in Talks with Delek Group for Phoenix Holdings Stake
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
